BNVA 150 (Boniva 150 mg)

Generic Name: ibandronate

This pill with imprint "BNVA 150" is White, Elliptical / Oval and has been identified as Boniva 150 mg. It is manufactured by Roche Laboratories.

Boniva is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Boniva

Generic Name:

ibandronate

Imprint:

BNVA 150

Strength:

150 mg

Color:

White

Size:

14.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Bisphosphonates

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Roche Laboratories

National Drug Code (NDC):

00004-0186

Inactive Ingredients:

lactose monohydrate
povidone k25
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54868-5322	Physicians Total Care Inc (repackager)
35356-0423	Lake Erie Medical and Surgical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.